Superiority of TPGS-loaded micelles in the brain delivery of vinpocetine via administration of thermosensitive intranasal gel

References

• Henry R, Ruano N, Casto D, Wolf R. A pharmacokinetic study of midazolam in dogs: nasal drop vs. atomizer administration. Pediatr Dent. 1998;20(5):321–326.9803431
   PubMedGoogle Scholar
• Pires PC, Santos AO. Nanosystems in nose-to-brain drug delivery: a review of non-clinical brain targeting studies. J Control Release. 2018;270:89–100. doi:10.1016/J.JCONREL.2017.11.04729199063
   PubMed Web of Science ®Google Scholar
• Dhuria SV, Hanson LR, Frey WH. Intranasal delivery to the central nervous system: mechanisms and experimental considerations. J Pharm Sci. 2010;99(4):1654–1673. doi:10.1002/jps.2192419877171
   PubMed Web of Science ®Google Scholar
• Agrawal M, Saraf S, Saraf S, et al. Nose-to-brain drug delivery: an update on clinical challenges and progress towards approval of anti-Alzheimer drugs. J Control Release. 2018;281:139–177. doi:10.1016/j.jconrel.2018.05.01129772289
   PubMed Web of Science ®Google Scholar
• Liu Z, Jiang M, Kang T, et al. Lactoferrin-modified PEG-co-PCL nanoparticles for enhanced brain delivery of NAP peptide following intranasal administration. Biomaterials. 2013;34(15):3870–3881. doi:10.1016/j.biomaterials.2013.02.00323453061
   PubMedGoogle Scholar
• El-Zaafarany GM, Soliman ME, Mansour S, Awad GAS. Identifying lipidic emulsomes for improved oxcarbazepine brain targeting: in vitro and rat in vivo studies. Int J Pharm. 2016;503(1–2):127–140. doi:10.1016/j.ijpharm.2016.02.03826924357
   PubMedGoogle Scholar
• Salama HA, Mahmoud AA, Kamel AO, Abdel HM, Awad GAS. Phospholipid based colloidal poloxamer-nanocubic vesicles for brain targeting via the nasal route. Colloids Surf B. 2012;100:146–154. doi:10.1016/j.colsurfb.2012.05.010
   PubMed Web of Science ®Google Scholar
• Illum L. Transport of drugs from the nasal cavity to the central nervous system. Eur J Pharm Sci. 2000;11(1):1–18. doi:10.1016/S0928-0987(00)00087-710913748
   PubMed Web of Science ®Google Scholar
• Minn A, Leclerc S, Heydel JM, et al. Drug transport into the mammalian brain: the nasal pathway and its specific metabolic barrier. J Drug Target. 2002;10(4):285–296. doi:10.1080/71371445212164377
   PubMed Web of Science ®Google Scholar
• Lockman PR, Mumper RJ, Khan MA, Allen DD. Nanoparticle technology for drug delivery across the blood-brain barrier. Drug Dev Ind Pharm. 2002;28(1):1–13. doi:10.1081/DDC-12000148111858519
   PubMed Web of Science ®Google Scholar
• Feng Y, He H, Li F, Lu Y, Qi J, Wu W. An update on the role of nanovehicles in nose-to-brain drug delivery. Drug Discov Today. 2018;23(5):1079–1088. doi:10.1016/J.DRUDIS.2018.01.00529330120
   PubMed Web of Science ®Google Scholar
• Ugwoke MI, Verbeke N, Kinget R. The biopharmaceutical aspects of nasal mucoadhesive drug delivery. J Pharm Pharmacol. 2001;53(1):3–22. doi:10.1211/002235701177514511206189
   PubMed Web of Science ®Google Scholar
• Davis ME, Chen Z, Shin DM. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov. 2008;7(9):771–782. doi:10.1038/nrd261418758474
   PubMed Web of Science ®Google Scholar
• Fenske DB, Cullis PR. Liposomal nanomedicines. Expert Opin Drug Deliv. 2008;5(1):25–44. doi:10.1517/17425247.5.1.2518095927
   PubMed Web of Science ®Google Scholar
• Puri A, Loomis K, Smith B, et al. Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic. Crit Rev Ther Drug Carrier Syst. 2009;26(6):523–580. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20402623. Accessed October 10, 2018. doi:10.1615/CritRevTherDrugCarrierSyst.v26.i6.1020402623
   PubMed Web of Science ®Google Scholar
• Ahmed TA, El-Say KM, Aljaeid BM, Fahmy UA, Abd-Allah FI. Transdermal glimepiride delivery system based on optimized ethosomal nano-vesicles: preparation, characterization, in vitro, ex vivo and clinical evaluation. Int J Pharm. 2016;500(1–2):245–254. doi:10.1016/j.ijpharm.2016.01.01726775063
   PubMed Web of Science ®Google Scholar
• Badr-Eldin SM, Ahmed OAA. Optimized nano-transfersomal films for enhanced sildenafil citrate transdermal delivery: ex vivo and in vivo evaluation. Drug Des Devel Ther. 2016;10:1323–1333. doi:10.2147/DDDT.S103122
   PubMed Web of Science ®Google Scholar
• Ahmed TA. Preparation of transfersomes encapsulating sildenafil aimed for transdermal drug delivery: plackett–burman design and characterization. J Liposome Res. 2015;25(1):1–10. doi:10.3109/08982104.2014.95027625148294
   PubMed Web of Science ®Google Scholar
• Zhang X-G, Miao J, Dai Y-Q, Du Y-Z, Yuan H, Hu F-Q. Reversal activity of nanostructured lipid carriers loading cytotoxic drug in multi-drug resistant cancer cells. Int J Pharm. 2008;361(1–2):239–244. doi:10.1016/j.ijpharm.2008.06.00218586075
   PubMed Web of Science ®Google Scholar
• Martins S, Sarmento B, Ferreira DC, Souto EB. Lipid-based colloidal carriers for peptide and protein delivery–liposomes versus lipid nanoparticles. Int J Nanomedicine. 2007;2(4):595–607. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18203427. Accessed October 10, 2018.18203427
   PubMed Web of Science ®Google Scholar
• El-Say KM, Hosny KM. Optimization of carvedilol solid lipid nanoparticles: an approach to control the release and enhance the oral bioavailability on rabbits. Ahmad A, ed. PLoS One. 2018;13(8):e0203405. doi:10.1371/JOURNAL.PONE.020340530161251
   PubMed Web of Science ®Google Scholar
• Zhang Y, Huang Y, Li S. Polymeric micelles: nanocarriers for cancer-targeted drug delivery. AAPS PharmSciTech. 2014;15(4):862–871. doi:10.1208/s12249-014-0113-z24700296
   PubMed Web of Science ®Google Scholar
• Varma MVS, Panchagnula R. Enhanced oral paclitaxel absorption with vitamin E-TPGS: effect on solubility and permeability in vitro, in situ and in vivo. Eur J Pharm Sci. 2005;25(4–5):445–453. doi:10.1016/j.ejps.2005.04.00315890503
   PubMed Web of Science ®Google Scholar
• Zhang Z, Tan S, Feng -S-S. Vitamin E TPGS as a molecular biomaterial for drug delivery. Biomaterials. 2012;33(19):4889–4906. doi:10.1016/j.biomaterials.2012.03.04622498300
   PubMed Web of Science ®Google Scholar
• Tan S, Zou C, Zhang W, Yin M, Gao X, Tang Q. Recent developments in d -α-tocopheryl polyethylene glycol-succinate-based nanomedicine for cancer therapy. Drug Deliv. 2017;24(1):1831–1842. doi:10.1080/10717544.2017.140656129182031
   PubMed Web of Science ®Google Scholar
• Dintaman JM, Silverman JA, Inhibition of P-glycoprotein by D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS). Pharm Res. 1999;16(10):1550–1556. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10554096. Accessed October 12, 2018. doi:10.1023/A:101500050362910554096
   PubMed Web of Science ®Google Scholar
• Ogunrin A. Effect of vinpocetine (cognitolTM) on cognitive performances of a nigerian population. Ann Med Health Sci Res. 2014;4(4):654–661. doi:10.4103/2141-9248.13936825221724
   PubMedGoogle Scholar
• Luo Y, Chen D, Ren L, Zhao X, Qin J. Solid lipid nanoparticles for enhancing vinpocetine’s oral bioavailability. J Control Release. 2006;114:53–59. doi:10.1016/j.jconrel.2006.05.01016828192
   PubMed Web of Science ®Google Scholar
• Liu M, Zhang S, Cui S, et al. Preparation and evaluation of Vinpocetine self-emulsifying pH gradient release pellets. Drug Deliv. 2017;24(1):1598–1604. doi:10.1080/10717544.2017.138845329043863
   PubMed Web of Science ®Google Scholar
• Harbi I, Aljaeid B, El-Say KM, Zidan AS. Glycosylated sertraline-loaded liposomes for brain targeting: qbD study of formulation variabilities and brain transport. AAPS PharmSciTech. 2016;17(6):1404–1420. doi:10.1208/s12249-016-0481-726786680
   PubMed Web of Science ®Google Scholar
• Ahmed TA, Badr-Eldin SM, Ahmed OAA, Aldawsari H. Intranasal optimized solid lipid nanoparticles loaded in situ gel for enhancing trans-mucosal delivery of simvastatin. J Drug Deliv Sci Technol. 2018;48(July):499–508. doi:10.1016/J.JDDST.2018.10.027
   Google Scholar
• Ahmed OAA, Badr-Eldin SM. In situ misemgel as a multifunctional dual-absorption platform for nasal delivery of raloxifene hydrochloride: formulation, characterization, and in vivo performance. Int J Nanomedicine. 2018;13:6325–6335. doi:10.2147/IJN.S18158730349253
   PubMed Web of Science ®Google Scholar
• Ahmed OAA, El-Say KM, Aljaeid BM, Badr-Eldin SM, Ahmed TA. Optimized vinpocetine-loaded vitamin E D- α - tocopherol polyethylene glycol 1000 succinate- alpha lipoic acid micelles as a potential transdermal drug delivery system : in vitro and ex vivo studies. Int J Nanomedicine. 2019;14:33–43. doi:10.2147/IJN.S18747030587983
   PubMed Web of Science ®Google Scholar
• Hao J, Wang X, Bi Y, et al. Fabrication of a composite system combining solid lipid nanoparticles and thermosensitive hydrogel for challenging ophthalmic drug delivery. Colloids Surf B. 2014;114:111–120. doi:10.1016/j.colsurfb.2013.09.059
   PubMed Web of Science ®Google Scholar
• Silva AC, González-Mira E, García ML, et al. Preparation, characterization and biocompatibility studies on risperidone-loaded solid lipid nanoparticles (SLN): high pressure homogenization versus ultrasound. Colloids Surf B. 2011;86(1):158–165. doi:10.1016/j.colsurfb.2011.03.035
   PubMed Web of Science ®Google Scholar
• Cevc G, Blume G, Schätzlein A. Transfersomes-mediated transepidermal delivery improves the regio-specificity and biological activity of corticosteroids in vivo1Dedicated to the late Dr. Henri Ernest Bodde.1. J Control Release. 1997;45(3):211–226. doi:10.1016/S0168-3659(96)01566-0
   Web of Science ®Google Scholar
• Ding J, Li J, Mao S. Development and evaluation of vinpocetine inclusion complex for brain targeting. Asian J Pharm Sci. 2015;10:114–120. doi:10.1016/j.ajps.2014.08.008
   Web of Science ®Google Scholar
• Duan Y, Wang J, Yang X, Du H, Xi Y, Zhai G. Curcumin-loaded mixed micelles: preparation, optimization, physicochemical properties and cytotoxicity in vitro. Drug Deliv. 2015;22(1):50–57. doi:10.3109/10717544.2013.87350124417664
   PubMed Web of Science ®Google Scholar
• Choi SG, Lee S-E, Kang B-S, Ng CL, Davaa E, Park J-S. Thermosensitive and mucoadhesive sol-gel composites of paclitaxel/dimethyl-β-cyclodextrin for buccal delivery. Xu B, ed. PLoS One. 2014;9(10):e109090. doi:10.1371/journal.pone.010909025275485
   PubMedGoogle Scholar
• Gilbert JC, Richardson JL, Davies MC, Palin KJ, Hadgraft J. The effect of solutes and polymers on the gelation properties of pluronic F-127 solutions for controlled drug delivery. J Control Release. 1987;5(2):113–118. doi:10.1016/0168-3659(87)90002-2
   Google Scholar
• García MC, Aldana AA, Tártara LI, et al. Bioadhesive and biocompatible films as wound dressing materials based on a novel dendronized chitosan loaded with ciprofloxacin. Carbohydr Polym. 2017;175:75–86. doi:10.1016/j.carbpol.2017.07.05328917926
   PubMed Web of Science ®Google Scholar
• Karasulu E, Yavaşoǧlu A, Evrenşanal Z, Uyanikgil Y, Karasulu HY. Permeation studies and histological examination of sheep nasal mucosa following administration of different nasal formulations with or without absorption enhancers. Drug Deliv. 2008;15(4):219–225. doi:10.1080/1071754080200637718446567
   PubMed Web of Science ®Google Scholar
• Yang C, Wu T, Qi Y, Zhang Z. Recent advances in the application of vitamin E TPGS for drug delivery. Theranostics. 2018;8(2):464–485. doi:10.7150/thno.2271129290821
   PubMed Web of Science ®Google Scholar
• Zhu H, Chen H, Zeng X, et al. Co-delivery of chemotherapeutic drugs with vitamin E TPGS by porous PLGA nanoparticles for enhanced chemotherapy against multi-drug resistance. Biomaterials. 2014;35(7):2391–2400. doi:10.1016/j.biomaterials.2013.11.08624360574
   PubMed Web of Science ®Google Scholar
• Muthu MS, Avinash Kulkarni S, Liu Y, Feng -S-S. Development of docetaxel-loaded vitamin E TPGS micelles: formulation optimization, effects on brain cancer cells and biodistribution in rats. Nanomedicine. 2012;7(3):353–364. doi:10.2217/nnm.11.11122329606
   PubMed Web of Science ®Google Scholar
• Chaudhary B, Verma S. Preparation and evaluation of novel in situ gels containing acyclovir for the treatment of oral herpes simplex virus infections. Sci World J. 2014;2014:1–7. doi:10.1155/2014/280928
   Web of Science ®Google Scholar
• Qian S, Wong YC, Zuo Z. Development, characterization and application of in situ gel systems for intranasal delivery of tacrine. Int J Pharm. 2014;468(1–2):272–282. doi:10.1016/j.ijpharm.2014.04.01524709220
   PubMed Web of Science ®Google Scholar
• Lindemann J, Leiacker R, Rettinger G, Keck T. Nasal mucosal temperature during respiration. Clin Otolaryngol Allied Sci. 2002;27(3):135–139. doi:10.1046/j.1365-2273.2002.00544.x12071984
   PubMed Web of Science ®Google Scholar
• Proctor DF, Andersen I, Lundqvist GR. Human nasal mucosal function at controlled temperatures. Respir Physiol. 1977;30(1–2):109–124. doi:10.1016/0034-5687(77)90025-1877442
   PubMedGoogle Scholar
• Jacky JP. Barometric measurement of tidal volume: effects of pattern and nasal temperature. J Appl Physiol. 1980;49(2):319–325. doi:10.1152/jappl.1980.49.2.3196772618
   PubMed Web of Science ®Google Scholar
• Wissing SA, Müller RH. The influence of solid lipid nanoparticles on skin hydration and viscoelasticity - In vivo study. Eur J Pharm Biopharm. 2003;56(1):67–72. doi:10.1016/S0939-6411(03)00040-712837483
   PubMed Web of Science ®Google Scholar
• Fang JY, Fang CL, Liu CH, Su YH. Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC). Eur J Pharm Biopharm. 2008;70(2):633–640. doi:10.1016/j.ejpb.2008.05.00818577447
   PubMed Web of Science ®Google Scholar
• Aboud HM, El Komy MH, Ali AA, El Menshawe SF, Abd Elbary A. Development, optimization, and evaluation of carvedilol-loaded solid lipid nanoparticles for intranasal drug delivery. AAPS PharmSciTech. 2016;17(6):1–13. doi:10.1208/s12249-015-0440-826860744
   PubMedGoogle Scholar
• Guo Y, Luo J, Tan S, Otieno BO, Zhang Z. The applications of Vitamin e TPGS in drug delivery. Eur J Pharm Sci. 2013;49(2):175–186. doi:10.1016/j.ejps.2013.02.00623485439
   PubMed Web of Science ®Google Scholar
• Beig A, Fine-Shamir N, Porat D, Lindley D, Miller JM, Dahan A. Concomitant solubility-permeability increase: vitamin E TPGS vs. amorphous solid dispersion as oral delivery systems for etoposide. Eur J Pharm Biopharm. 2017;121:97–103. doi:10.1016/j.ejpb.2017.09.01228958946
   PubMed Web of Science ®Google Scholar
• Illum L. Nasal drug delivery - Possibilities, problems and solutions. J Controlled Release. 2003;87:187–198. doi:10.1016/S0168-3659(02)00363-2
   PubMed Web of Science ®Google Scholar
• Graff CL, Pollack GM. Functional evidence for P-glycoprotein at the nose-brain barrier. Pharm Res. 2005;22(1):86–93. doi:10.1007/s11095-004-9013-315771234
   PubMed Web of Science ®Google Scholar
• Graff CL, Pollack GM. P-glycoprotein attenuates brain uptake of substrates after nasal instillation. Pharm Res. 2003;20(8):1225–1230. doi:10.1023/A:102505311558312948020
   PubMedGoogle Scholar